$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
The new global treatment landscape of Tucatinib/Tucatinib in 2025: a key turning point for HER2 targeting to enter the "precision small molecule era"
2026-02-01 22:25:32
Check Details
Axitinib (Inlida) dose adjustment principles and adjustment methods in different situations
2026-02-01 22:25:32
Check Details
Trametinib (Megenin) is suitable for use and dose adjustment in patients with liver and kidney dysfunction
2026-02-01 22:25:32
Check Details
Is avatrombopag safe for children aged 7 years to take?
2026-02-01 22:25:32
Check Details
The optimal taking time and daily dose distribution recommendations for giritinib (segatan)
2026-02-01 22:25:32
Check Details
Analysis of common side effects and symptoms of Osimertinib (Tagressa)
2026-02-01 22:25:32
Check Details
Can eltrombopag (Revlan) cure patients with thrombocytopenia?
2026-02-01 22:25:32
Check Details
What is the effect of Roprostim (Huier Ning) on u200bu200bincreasing platelets and its clinical evaluation?
2026-02-01 22:25:32
Check Details
Detailed explanation of the main functions and clinical application value of Midostaurin
2026-02-01 22:25:32
Check Details
How long does it take to take Cabergoline to achieve the desired effect?
2026-02-01 22:25:32
Check Details
Analysis of detailed Chinese instructions and medication guide for Momelotinib
2026-02-01 22:25:32
Check Details
The correct taking time and optimal daily dosing schedule of Bikken Pronol Tablets (Bituvi)
2026-02-01 22:25:32
Check Details
1
2
...
2244
2245
2246
2247
2248
2249
2250
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma